1. Home
  2. BBIO vs WLK Comparison

BBIO vs WLK Comparison

Compare BBIO & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • WLK
  • Stock Information
  • Founded
  • BBIO 2015
  • WLK 1986
  • Country
  • BBIO United States
  • WLK United States
  • Employees
  • BBIO N/A
  • WLK N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • WLK Major Chemicals
  • Sector
  • BBIO Health Care
  • WLK Industrials
  • Exchange
  • BBIO Nasdaq
  • WLK Nasdaq
  • Market Cap
  • BBIO 10.4B
  • WLK 10.1B
  • IPO Year
  • BBIO 2019
  • WLK 2004
  • Fundamental
  • Price
  • BBIO $61.73
  • WLK $64.74
  • Analyst Decision
  • BBIO Strong Buy
  • WLK Buy
  • Analyst Count
  • BBIO 18
  • WLK 16
  • Target Price
  • BBIO $74.28
  • WLK $92.31
  • AVG Volume (30 Days)
  • BBIO 2.7M
  • WLK 1.2M
  • Earning Date
  • BBIO 10-29-2025
  • WLK 10-30-2025
  • Dividend Yield
  • BBIO N/A
  • WLK 3.26%
  • EPS Growth
  • BBIO N/A
  • WLK N/A
  • EPS
  • BBIO N/A
  • WLK N/A
  • Revenue
  • BBIO $353,780,000.00
  • WLK $11,480,000,000.00
  • Revenue This Year
  • BBIO $123.32
  • WLK N/A
  • Revenue Next Year
  • BBIO $73.46
  • WLK $3.14
  • P/E Ratio
  • BBIO N/A
  • WLK N/A
  • Revenue Growth
  • BBIO 62.46
  • WLK N/A
  • 52 Week Low
  • BBIO $21.72
  • WLK $63.92
  • 52 Week High
  • BBIO $69.48
  • WLK $137.95
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 59.65
  • WLK 27.37
  • Support Level
  • BBIO $60.23
  • WLK $65.77
  • Resistance Level
  • BBIO $64.44
  • WLK $70.62
  • Average True Range (ATR)
  • BBIO 3.05
  • WLK 2.53
  • MACD
  • BBIO 0.06
  • WLK -1.00
  • Stochastic Oscillator
  • BBIO 53.68
  • WLK 5.18

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About WLK Westlake Corporation

Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

Share on Social Networks: